[go: up one dir, main page]

NO306977B1 - Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen - Google Patents

Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen

Info

Publication number
NO306977B1
NO306977B1 NO952130A NO952130A NO306977B1 NO 306977 B1 NO306977 B1 NO 306977B1 NO 952130 A NO952130 A NO 952130A NO 952130 A NO952130 A NO 952130A NO 306977 B1 NO306977 B1 NO 306977B1
Authority
NO
Norway
Prior art keywords
thienol
benzodiazepine
treatment
gastrointestinal disorders
gastrointestinal
Prior art date
Application number
NO952130A
Other languages
English (en)
Other versions
NO952130L (no
NO952130D0 (no
Inventor
Beverley Greenwood
David Lloyd Garver Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO952130D0 publication Critical patent/NO952130D0/no
Publication of NO952130L publication Critical patent/NO952130L/no
Publication of NO306977B1 publication Critical patent/NO306977B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO952130A 1994-06-03 1995-05-30 Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen NO306977B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/253,658 US5457101A (en) 1994-06-03 1994-06-03 Thieno[1,5]benzoidiazepine use

Publications (3)

Publication Number Publication Date
NO952130D0 NO952130D0 (no) 1995-05-30
NO952130L NO952130L (no) 1995-12-04
NO306977B1 true NO306977B1 (no) 2000-01-24

Family

ID=22961179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952130A NO306977B1 (no) 1994-06-03 1995-05-30 Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen

Country Status (14)

Country Link
US (1) US5457101A (no)
EP (1) EP0685233B1 (no)
JP (1) JPH07330608A (no)
KR (1) KR960000229A (no)
CN (1) CN1119101A (no)
AU (1) AU684924B2 (no)
CA (1) CA2150517A1 (no)
DE (1) DE69528109D1 (no)
HU (1) HUT71598A (no)
IL (1) IL113912A (no)
NO (1) NO306977B1 (no)
NZ (1) NZ272231A (no)
TW (1) TW372872B (no)
ZA (1) ZA954358B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
CZ290298A3 (cs) * 1996-03-11 1999-10-13 Eli Lilly And Company Farmaceutický prostředek proti bipolárních poruše
WO1997033585A1 (en) * 1996-03-11 1997-09-18 Eli Lilly And Company Method for treating autism
CN1219878A (zh) * 1996-03-25 1999-06-16 伊莱利利公司 治疗疼痛的方法
PL187926B1 (pl) * 1996-03-25 2004-11-30 Lilly Co Eli Kompozycja farmaceutyczna do leczenia bólu
KR20000004966A (ko) * 1996-03-25 2000-01-25 피터 지. 스트링거 편두통 치료 방법
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
WO1998046596A1 (en) * 1997-04-15 1998-10-22 Eli Lilly And Company Method for providing neuro-protective effects
US20030022889A1 (en) * 1997-04-15 2003-01-30 Bymaster Franklin P. Method for providing neuro-protective effects
EP1133299A1 (en) 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
EP1135136B1 (en) * 1998-11-23 2003-11-05 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
WO2000030650A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
US6348458B1 (en) 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
GB0207091D0 (en) * 2002-03-26 2002-05-08 Ml Lab Plc Method of treatment
US7407788B2 (en) * 2002-11-21 2008-08-05 Danisco A/S, Genencor Division BGL7 beta-glucosidase and nucleic acids encoding the same
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
GB0314149D0 (en) * 2003-06-18 2003-07-23 Generics Uk Ltd Novel amorphous forms
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
DE602005027308D1 (de) * 2004-01-27 2011-05-19 Synthon Bv Stabile salze von olanzapin
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP2246086A3 (en) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heating unit
EA013433B1 (ru) * 2005-02-15 2010-04-30 Элан Фарма Интернэшнл Лтд. Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
EP1919923A1 (en) * 2005-08-17 2008-05-14 Synthon B.V. A process for making olanzapine form i
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
AR063043A1 (es) * 2006-09-29 2008-12-23 Synthon Bv Composicion farmaceutica de olanzapina
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
WO2012051502A1 (en) 2010-10-14 2012-04-19 University Of Utah Research Foundation Methods and compositions related to neuroactive thiazoline compounds
EP3497105A1 (en) * 2016-08-11 2019-06-19 Eli Lilly And Company Aminothiazines and their use as bace1 inhibitors
KR102852740B1 (ko) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. 전기적 응축 에어로졸 디바이스

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
CA2097016A1 (en) * 1992-05-29 1993-11-30 John Fairhurst Pharmaceutical compounds
EP0620222A3 (en) * 1993-04-14 1995-04-12 Lilly Co Eli Tetrahydro-beta-carbolines.
CZ264996A3 (cs) * 1994-03-11 1998-01-14 Eli Lilly And Company Použití sloučenin, které jsou aktivní na 5HT2B receptor

Also Published As

Publication number Publication date
EP0685233A2 (en) 1995-12-06
IL113912A0 (en) 1995-08-31
ZA954358B (en) 1996-11-29
EP0685233A3 (en) 1996-04-03
EP0685233B1 (en) 2002-09-11
US5457101A (en) 1995-10-10
HU9501600D0 (en) 1995-07-28
DE69528109D1 (de) 2002-10-17
NO952130L (no) 1995-12-04
NZ272231A (en) 2001-05-25
NO952130D0 (no) 1995-05-30
HUT71598A (en) 1996-01-29
IL113912A (en) 1999-04-11
TW372872B (en) 1999-11-01
CN1119101A (zh) 1996-03-27
JPH07330608A (ja) 1995-12-19
KR960000229A (ko) 1996-01-25
CA2150517A1 (en) 1995-12-04
AU684924B2 (en) 1998-01-08
AU2042495A (en) 1995-12-14

Similar Documents

Publication Publication Date Title
NO306977B1 (no) Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen
IL116998A0 (en) Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
HUP0104676A3 (en) Compositions for the treatment of anorectal disorders and their use
FI965154L (fi) Lääkkeen paksusuoleen kuljettava koostumus
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
NO974569D0 (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO982562D0 (no) Sammensetning for behandling av smerte
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO991158D0 (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002